2026 Interim report
Filed with HKEX · Stock code 2659 · · 81 pages · English
CORPORATE INFORMATION BUSINESS HIGHLIGHTS FINANCIAL HIGHLIGHTS MANAGEMENT DISCUSSION AND ANALYSIS 2 4 13 14 CORPORATE GOVERNANCE AND OTHER INFORMATION 41 INDEPENDENT REVIEW REPORT 54 INTERIM CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS 55 INTERIM CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 56 INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION INTERIM CONDENSED CONSOL
Shanghai Bao Pharmaceuticals Co Ltd on 6ix
Earlier from Shanghai Bao Pharmaceuticals
Later from Shanghai Bao Pharmaceuticals
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - ind for BJ045 for injection was approved by nmpa
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Shanghai Bao Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Bao Pharmaceuticals